|
1
|
An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies.
|
Rheumatology (Oxford)
|
2002
|
1.74
|
|
2
|
The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint.
|
Arthritis Rheum
|
1998
|
1.53
|
|
3
|
The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction.
|
Arthritis Rheum
|
2002
|
1.52
|
|
4
|
Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines.
|
Ann Rheum Dis
|
2002
|
1.31
|
|
5
|
Differential Toll-like receptor-dependent collagenase expression in chondrocytes.
|
Ann Rheum Dis
|
2008
|
1.19
|
|
6
|
Identification of the pathogenic pathways in osteoarthritic hip cartilage: commonality and discord between hip and knee OA.
|
Osteoarthritis Cartilage
|
2012
|
1.17
|
|
7
|
Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo.
|
Arthritis Rheum
|
2003
|
1.15
|
|
8
|
Differential changes in the association and dissociation rate constants for binding of cystatins to target proteinases occurring on N-terminal truncation of the inhibitors indicate that the interaction mechanism varies with different enzymes.
|
Biochem J
|
1994
|
1.12
|
|
9
|
Activation of procathepsin B in human hepatoma cells: the conversion into the mature enzyme relies on the action of cathepsin B itself.
|
Biochem J
|
1993
|
1.12
|
|
10
|
Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis.
|
Arthritis Rheum
|
2006
|
1.10
|
|
11
|
Stem bromelain: amino acid sequence and implications for weak binding of cystatin.
|
FEBS Lett
|
1989
|
1.07
|
|
12
|
Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha.
|
Ann Rheum Dis
|
2001
|
1.05
|
|
13
|
Emerging roles of serine proteinases in tissue turnover in arthritis.
|
Arthritis Rheum
|
2008
|
1.05
|
|
14
|
Interleukin-1 in combination with oncostatin M up-regulates multiple genes in chondrocytes: implications for cartilage destruction and repair.
|
Arthritis Rheum
|
2006
|
1.04
|
|
15
|
Interleukin 13 blocks the release of collagen from bovine nasal cartilage treated with proinflammatory cytokines.
|
Ann Rheum Dis
|
2001
|
0.99
|
|
16
|
Synergistic induction of matrix metalloproteinase 1 by interleukin-1alpha and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism.
|
Arthritis Rheum
|
2001
|
0.99
|
|
17
|
Modulation of the expression of matrix metalloproteinase and tissue inhibitors of metalloproteinases by TGF-beta1 and IGF-1 in primary human articular and bovine nasal chondrocytes stimulated with TNF-alpha.
|
Cytokine
|
2001
|
0.98
|
|
18
|
The inhibition of metalloproteinases as a therapeutic target in rheumatoid arthritis and osteoarthritis.
|
Curr Opin Pharmacol
|
2001
|
0.96
|
|
19
|
Transcriptional activity of the human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1.
|
Biochem J
|
1997
|
0.95
|
|
20
|
Retinoic acid combines with interleukin-1 to promote the degradation of collagen from bovine nasal cartilage: matrix metalloproteinases-1 and -13 are involved in cartilage collagen breakdown.
|
J Cell Biochem
|
2000
|
0.95
|
|
21
|
Oncostatin M in combination with tumour necrosis factor {alpha} induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or -2.
|
Ann Rheum Dis
|
2005
|
0.93
|
|
22
|
96-Well plate assays for measuring collagenase activity using (3)H-acetylated collagen.
|
Anal Biochem
|
1999
|
0.91
|
|
23
|
Assessment of the clinical significance of gelatinase activity in patients with juvenile idiopathic arthritis using quantitative protein substrate zymography.
|
Ann Rheum Dis
|
2005
|
0.91
|
|
24
|
Transforming growth factor beta1 blocks the release of collagen fragments from boving nasal cartilage stimulated by oncostatin M in combination with IL-1alpha.
|
Cytokine
|
2000
|
0.89
|
|
25
|
Transforming growth factor beta 1 and insulin-like growth factor 1 block collagen degradation induced by oncostatin M in combination with tumour necrosis factor alpha from bovine cartilage.
|
Ann Rheum Dis
|
2003
|
0.89
|
|
26
|
Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study.
|
Rheumatology (Oxford)
|
2005
|
0.88
|
|
27
|
Inhibition of furin-like enzymes blocks interleukin-1alpha/oncostatin M-stimulated cartilage degradation.
|
Arthritis Rheum
|
2003
|
0.88
|
|
28
|
Development of a novel 2D proteomics approach for the identification of proteins secreted by primary chondrocytes after stimulation by IL-1 and oncostatin M.
|
Rheumatology (Oxford)
|
2006
|
0.88
|
|
29
|
Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.
|
Rheumatology (Oxford)
|
2006
|
0.85
|
|
30
|
Human nasal cartilage responds to oncostatin M in combination with interleukin 1 or tumour necrosis factor alpha by the release of collagen fragments via collagenases.
|
Ann Rheum Dis
|
2005
|
0.83
|
|
31
|
Esculetin inhibits cartilage resorption induced by interleukin 1alpha in combination with oncostatin M.
|
Ann Rheum Dis
|
2001
|
0.80
|
|
32
|
A computer simulation approach to assessing therapeutic intervention points for the prevention of cytokine-induced cartilage breakdown.
|
Arthritis Rheumatol
|
2014
|
0.79
|
|
33
|
Preparation of recombinant tissue inhibitor of metalloproteinases-1 (TIMP-1) in high yield and identification of a hydrophobic surface feature.
|
Eur J Biochem
|
1998
|
0.79
|
|
34
|
Retinoic acid and oncostatin M combine to promote cartilage degradation via matrix metalloproteinase-13 expression in bovine but not human chondrocytes.
|
Rheumatology (Oxford)
|
2006
|
0.79
|
|
35
|
Investigation of structure function relationships in cathepsin B.
|
Biol Chem Hoppe Seyler
|
1992
|
0.79
|
|
36
|
Assay of matrix metalloproteinases against matrix substrates.
|
Methods Mol Biol
|
2001
|
0.77
|
|
37
|
Cryptic promoter activity of pBLCAT3 induced by overexpression of AP1 factors.
|
Biotechniques
|
2002
|
0.77
|